Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H34O3 |
| Molecular Weight | 334.4929 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C=C1\CC[C@H]2[C@@H]3[C@@H](O)[C@H](O)[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=MBRMDGSBOOLIGQ-QYJZNYBASA-N
InChI=1S/C21H34O3/c1-4-12-5-6-14-17-15(8-10-20(12,14)2)21(3)9-7-13(22)11-16(21)18(23)19(17)24/h4,13-19,22-24H,5-11H2,1-3H3/b12-4-/t13-,14-,15-,16+,17-,18+,19+,20+,21+/m0/s1
| Molecular Formula | C21H34O3 |
| Molecular Weight | 334.4929 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:39:42 GMT 2025
by
admin
on
Tue Apr 01 16:39:42 GMT 2025
|
| Record UNII |
2W88J8M5VR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2W88J8M5VR
Created by
admin on Tue Apr 01 16:39:42 GMT 2025 , Edited by admin on Tue Apr 01 16:39:42 GMT 2025
|
PRIMARY | |||
|
10925684
Created by
admin on Tue Apr 01 16:39:42 GMT 2025 , Edited by admin on Tue Apr 01 16:39:42 GMT 2025
|
PRIMARY | |||
|
202415-99-4
Created by
admin on Tue Apr 01 16:39:42 GMT 2025 , Edited by admin on Tue Apr 01 16:39:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
In a rat ovalbumin lung inflammation model, orally administered IPL576,092 significantly inhibited the challenge-mediated increase in total bronchoalveolar lavage leukocyte numbers, and macrophage and lymphocyte infiltration (1-10 mg/kg/day).
|